A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing entirely in some cases

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

A promising triple-action cancer jab being trialled at the Royal Marsden has shown encouraging results for some patients with head and neck cancer, with tumours disappearing…

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago